NovaBay Pharmaceuticals (NBY) Q3 2024 Earnings

Aug 13Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-5.25
-3.62
-2
-0.37

Details

Expected EPS
-1.225
Actual EPS
-1.37
Surprise EPS
-0.15
Surprise Percent
-11.84%

Description

⁨NovaBay Pharmaceuticals⁩ (⁦NBY⁩) has reported earnings of ⁦-1.37⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts